Wuhan MC Culture and Sports Co., Ltd. (SHA:600136)
China · Delayed Price · Currency is CNY 1.950
+0.010 (0.52%)
Aug 1, 2025, 3:00 PM CST
Regulus Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -95.1 | -101.02 | 2,864 | -4,724 | -977.77 | -1,961 | Upgrade |
Depreciation & Amortization | 13.61 | 13.61 | 13.29 | 219.65 | 444.68 | 601.32 | Upgrade |
Other Amortization | 5.79 | 5.79 | 1.62 | 6.56 | 7.98 | 16.31 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -2.02 | -0.87 | - | -0.17 | Upgrade |
Asset Writedown & Restructuring Costs | 62.64 | 62.64 | 7.9 | 2,398 | 416.16 | 305.94 | Upgrade |
Loss (Gain) From Sale of Investments | -0.05 | -0.05 | -4,824 | -23.48 | 0.59 | 125.37 | Upgrade |
Provision & Write-off of Bad Debts | 2.99 | 2.99 | 35.65 | 151.06 | 141.36 | 135.99 | Upgrade |
Other Operating Activities | -49.34 | -7.22 | 1,578 | 1,182 | 425.32 | 943.04 | Upgrade |
Change in Accounts Receivable | -83.66 | -83.66 | 277.48 | 407.1 | 472.14 | 600.62 | Upgrade |
Change in Inventory | -37.15 | -37.15 | 166.87 | -42.93 | -790.76 | -105.22 | Upgrade |
Change in Accounts Payable | 74.42 | 74.42 | -115.04 | 369.71 | 57.51 | -104.42 | Upgrade |
Operating Cash Flow | -109.8 | -73.6 | 5.4 | 78.41 | 130.49 | 481.69 | Upgrade |
Operating Cash Flow Growth | - | - | -93.12% | -39.91% | -72.91% | 34.78% | Upgrade |
Capital Expenditures | -14.94 | -13.1 | -1.76 | -0.59 | -2.79 | -364.35 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0.16 | 1.27 | - | 0.24 | Upgrade |
Cash Acquisitions | -56.24 | -56.24 | -0.08 | - | - | - | Upgrade |
Divestitures | - | - | - | - | - | 10.04 | Upgrade |
Investment in Securities | 0.16 | 0.16 | 3.2 | 4.05 | 100.91 | -24.18 | Upgrade |
Other Investing Activities | 185.53 | 185.53 | 46.45 | - | 27.36 | 0.17 | Upgrade |
Investing Cash Flow | 114.51 | 116.34 | 47.97 | 4.73 | 125.48 | -378.08 | Upgrade |
Short-Term Debt Issued | - | - | - | 75.89 | 2,675 | - | Upgrade |
Long-Term Debt Issued | - | 29.45 | 0.33 | - | 733.54 | 1,653 | Upgrade |
Total Debt Issued | 61.6 | 29.45 | 0.33 | 75.89 | 3,409 | 1,653 | Upgrade |
Short-Term Debt Repaid | - | - | -0.03 | - | -1,522 | - | Upgrade |
Long-Term Debt Repaid | - | -24.51 | -6.8 | -90.06 | - | -2,144 | Upgrade |
Total Debt Repaid | -50.66 | -24.51 | -6.83 | -90.06 | -1,522 | -2,144 | Upgrade |
Net Debt Issued (Repaid) | 10.94 | 4.94 | -6.5 | -14.16 | 1,886 | -490.67 | Upgrade |
Issuance of Common Stock | 1.28 | - | - | - | - | - | Upgrade |
Common Dividends Paid | -1.24 | -1.11 | - | -2.42 | -307.64 | -409.07 | Upgrade |
Other Financing Activities | -22.65 | -21.7 | - | - | -2,199 | 1,322 | Upgrade |
Financing Cash Flow | -11.67 | -17.87 | -6.5 | -16.58 | -620.4 | 422.44 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | -1.25 | 4.15 | -2.25 | -245.65 | Upgrade |
Net Cash Flow | -6.96 | 24.86 | 45.62 | 70.72 | -366.68 | 280.4 | Upgrade |
Free Cash Flow | -124.73 | -86.71 | 3.64 | 77.82 | 127.69 | 117.34 | Upgrade |
Free Cash Flow Growth | - | - | -95.33% | -39.06% | 8.83% | - | Upgrade |
Free Cash Flow Margin | -22.53% | -20.21% | 0.69% | 10.51% | 8.22% | 16.77% | Upgrade |
Free Cash Flow Per Share | - | -0.04 | 0.00 | 0.13 | 0.22 | 0.20 | Upgrade |
Cash Income Tax Paid | 28.46 | 18.81 | 18.77 | 4.38 | 56.99 | 42.77 | Upgrade |
Levered Free Cash Flow | 129.32 | 183.18 | -4,617 | 1,630 | 760.67 | 1,745 | Upgrade |
Unlevered Free Cash Flow | 133.95 | 186.52 | -4,406 | 1,917 | 1,012 | 2,123 | Upgrade |
Change in Net Working Capital | -146.59 | -205.39 | 4,330 | -2,770 | -668.64 | -2,478 | Upgrade |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.